Opiant Pharmaceuticals Inc (NASDAQ:OPNT)

25.39
Delayed Data
As of Feb 16
 -1.11 / -4.19%
Today’s Change
5.00
Today|||52-Week Range
51.90
+10.54%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues0.001.6M9.9M18.4M
 
 
 
 
Depreciation And Amortization1.4K1.4K2.4K5.1K
 
 
 
 
 
 
Operating ExpensesGross Income-1.4K------
 
 
General Expenses11.3M8.4M17.6M11.3M
 
 
 
 
 
Research And Development464.6K2.4M1.7M3.2M
 
 
 
 
 
Total Operating Expenses11.3M8.4M17.6M11.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-11.3M-6.9M-7.7M7.1M
 
 
 
 
 
Extraordinary Credit20.7K0.000.000.00
 
 
Extraordinary Charge-27.1K0.000.000.00
 
 
Interest Expense On Debt160.3K28.2K11.9K3.7K
 
 
 
 
 
Other Expenses-12.7K-110.1K-63.9K18.4K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.5M-7.0M-7.8M7.1M
 
 
 
 
 
Income Taxes0.000.000.00-550.5K
 
 
Net Income-11.5M-7.0M-7.8M6.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.7M4.0M1.9M2.0M
 
 
 
 
 
Shares To Calculate EPS Diluted1.7M4.0M1.9M2.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$7.00-$3.88-$4.09$2.94
 
 
 
 
 
EPS Diluted-$7.00-$1.75-$4.09$2.94